Palatin Technologies
PTN
#10927
Rank
$11.16 M
Marketcap
$6.27
Share price
9.81%
Change (1 day)
-50.75%
Change (1 year)

Palatin Technologies (PTN) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : $1.83 Million USD

According to Palatin Technologies's latest financial reports the company's total liabilities are $1.83 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Palatin Technologies - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30$17.8 M-10.09%
2022-06-30$19.8 M12.23%
2021-06-30$17.64 M261.52%
2020-06-30$4.88 M16.6%
2019-06-30$4.18 M-65.27%
2018-06-30$12.05 M-80.56%
2017-06-30$61.99 M117.96%
2016-06-30$28.44 M64.7%
2015-06-30$17.26 M523.41%
2014-06-30$2.77 M32.18%
2013-06-30$2.09 M-40.96%
2012-06-30$3.54 M19.07%
2011-06-30$2.98 M-2.92%
2010-06-30$3.07 M-68.94%
2009-06-30$9.88 M-21.37%
2008-06-30$12.57 M-48.15%
2007-06-30$24.24 M11.5%
2006-06-30$21.74 M-16.17%
2005-06-30$25.94 M208.32%
2004-06-30$8.41 M107.01%
2003-06-30$4.06 M10.71%
2002-06-30$3.67 M57.67%
2001-06-30$2.32 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$115.89 B 6,307,542.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$65.46 B 3,562,725.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$1.66 B 90,544.88%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
$3.16 M 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$1.21 B 66,209.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
$0.89 B 48,713.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
$2.61 M 42.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.42 B 23,133.01%๐Ÿ‡บ๐Ÿ‡ธ USA